Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) Stock Ticker

NASDAQ: TIL · Healthcare · Biotechnology
$7.17+0.70%
USD · as of 2026-09-27 · market cap $48.6M
Open TIL in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TIL picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TIL
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Instil Bio, Inc.

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

TIL stock facts

Ticker symbolTIL
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$48.6M
CEOBronson Crouch
Employees17
HeadquartersDallas, TX, US
IPO date2021-03-19
Websiteinstilbio.com

What you can see for TIL on Tickr

Live TIL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TIL report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Instil Bio, Inc.?

The ticker symbol for Instil Bio, Inc. is TIL, listed on the NASDAQ Global Select.

What is TIL?

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

HomeExploreMarketLists
All pages